期刊文献+

miR-26a靶向EZH2抑制涎腺腺样囊性癌ACC-M细胞的增殖活性 被引量:3

MiR-26a suppresses proliferation of salivary adenoid cystic carcinoma cells by targeting EZH2
暂未订购
导出
摘要 目的探讨miR-26a对涎腺腺样囊性癌ACC-M细胞增殖能力的影响及其与EZH2的靶向关系。方法构建pcDNATM6.2-pre-miR-26a、pmirGLO-EZH2野生型(pmirGLO-EZH2-WT)和突变型(pmirGLO-EZH2-MT)重组质粒,并采用荧光实时定量PCR(qRT-PCR)检测pre-miR-26a在ACC-M细胞中的转染效率,并与未处理组(control组)进行比较。同时采用MTT法分析miR-26a过表达对ACC-M细胞增殖活性的影响,并采用双荧光素酶报告基因系统、qRT-PCR和Western blot检测miR-26a与EZH2的靶向关系。结果将测序结果采用NCBI BLAST进行序列比对,结果显示pre-miR-26a、EZH2-WT和EZH2-MT重组质粒均构建成功,无碱基缺失或突变。qRT-PCR显示转染pre-miR-26a的ACC-M细胞其miR-26a的表达显著高于未处理组(P<0.001)。MTT分析显示miR-26过表达可以明显抑制ACC-M细胞的增殖活性(P<0.05)。此外,双荧光素酶报告基因系统(P=0.001)、qRT-PCR和Western blot均证实miR-26a能够显著下调EZH2的mRNA(P=0.001)和蛋白的表达(P=0.006)。结论 miR-26a能够显著抑制涎腺腺样囊性癌ACC-M细胞的增殖活性,并且与EZH2之间存在良好的靶向关系。 Objective To investigate the effect of miR-26a on proliferation of salivary adenoid cystic carcinoma cells (SACC) and its relationship with EZH2.Methods The pre-miR-126,EZH2-WT and EZH2-MT recombinant plasmid were synthesized and cloned into pcDNATM6.2 and pmirGLO plasmids respectively.The transfection efficiency of pre-miR-26a was identified by qRT-PCR.In addition,the effect of miR-26a on the proliferation of ACC-M cells was analyzed by MTT.The target relationship between miR-26a and EZH2 was identified by Dual-Luciferase Assay System,qRT-PCR and Western blot.Results The recombinant plasmids were successfully constructed,including pcDNATM6.2-pre-miR-26a,pmirGLO-EZH2-WT and pmirGLO-EZH2-MT.The miR-26a expression was increased in ACC-M cells after transfected with pre-miR-26a(P <0.001).MTT assay showed that miR-26 overexpression significantly inhibited the proliferation of ACC-M cells (P < 0.05).In addition,the target relationship between miR-26a and EZH2 was identified by Dual-Luciferase Assay System(P =0.001),and miR-26a decreased the mRNA(P =0.001) and protein expression levels of EZH2 (P =0.006).Conclusion The miR-26 overexpression could inhibit cell proliferation of salivary adenoid cystic carcinoma cells through targeting EZH2.
出处 《山西医科大学学报》 CAS 2014年第2期101-105,共5页 Journal of Shanxi Medical University
关键词 涎腺腺样囊性癌 miR-26a EZH2 细胞增殖 salivary adenoid cystic carcinoma miR-26a EZH2 cell proliferation
  • 相关文献

参考文献13

  • 1Tincani A J, Del Negro A, Aratljo PP, et al. Management of salivar- y gland adenoid cystic carcinoma: Institutional experience of a case series[ J]. Sao Paulo Med J ,2006,124 ( 1 ) :26 - 30.
  • 2He Q,Zhou X,Li S,et al. Mierorna-181a suppresses salivary ade- noid cystic earcinoma metastasis by targeting mapk - snai2 path- way[ J]. Biochim Biophys Acta,2013,1830( 11 ) :5258 -5266.
  • 3Chen D, Zhang B, Kang J, et al. Expression and clinical signifi- cance of fak, ilk, and pten in salivary adenoid cystic carcinoma [ J ]. Acta Otolaryngo1,2013,133 ( 2 ) :203 - 208.
  • 4Calin GA, Sevignani C, Dumitru CD,et al. Human mieroma genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci U S A,2004,101 (9) :2999 -3004.
  • 5Deng M, Tang HL, Lu XH, et al. miR-26a suppresses tumor growth and metastasis by targeting fgO in gastric cancer[ J ]. PIoS One ,2013,8 ( 8 ) : e72662.
  • 6Lin Y, Chen H, Hu Z, et al. miR-26a inhibits proliferation and motility in bladder cancer by targeting hmgal [ J ]. FEBS Lett, 2013,587 ( 15 ) :2467 - 2473.
  • 7Brazeo-Silva MT, Cardoso SV, de Faria PR, et al. Adenoid cystic carcinoma of the salivary gland : A clinicopathological study of 49 cases and of metallothionein expression with regard to tumour be~ haviour [ J ]. Histopathology, 2013,6 ( 6 ) : 802 - 809.
  • 8Dai W, Zhou Q, Xu Z, et al. Expression of tmprss4 in patients with salivary adenoid cystic carcinoma:Correlation with clinico- pathological features and prognosis [ J ]. Med Oncol, 2013,30 (4):1 -7.
  • 9Fu X,Meng Z,Liang W,et al. miR-26a enhances mirna biogene- sis by targeting lin28b and zcchcll to suppress tumor growth and metastasis[ J]. Oncogene,2013 : Epub ahead of print.
  • 10Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein ezh2 is involved in progression of prostate cancer [ J ]. Nature,2002,419 (6907) :624 - 629.

同被引文献55

  • 1孙沫逸,王磊,杨连甲,侯锐,孙文斌,卢超.NGF在涎腺腺样囊性癌中的表达及与嗜神经侵袭和疼痛的关系[J].第四军医大学学报,2004,25(11):1012-1014. 被引量:30
  • 2Liu B, Wu X, Liu B, et al. MiR-26a enchances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN [J]. Bio- chim Biophys Acta,2012,1822( 11 ) : 1692-1704.
  • 3Lu J, He ML, Wang L,et al. MiR-26a inhibits cell growth and tumor- igenesis of nasopharyngeal earcinoma through repression of EZH2 [J]. Cancer Res,2011,71 ( 1 ) :225-233.
  • 4Zhang B, Liu XX, He JR, et al. Pathologically decreased miR-26a antagonizes apoptusis and facilitates carcinogenesis by targeting MT- DH and EZH2 in breast cancer [J ]. Carcinogenesis, 2011,32 ( 1 ) : 2-9.
  • 5Kim H, Huang W ,Jiang X, et al. Integrative genome analysis reveals an oncomiriom:ngcne cluster regulating glioblastoma survivorship [J ]. Proc Natl Acad Sci USA,2010,107(5) :2183-2188.
  • 6Deng M, Tang HI,, Lu XH, et al. miR-26a suppresses tumor growth and metastasis by targeting fgt9 in gastric cancer [J]. PIoS One, 2013,8 (8) :e72662.
  • 7Lin Y, Chen H, Hu Z, et al. miR-26a inhibits pr'oliferation and motil-ity in Madder cancer by targeting hmgal [Jj. FEBS Lett, 2013,587 ( 15 ) : 2467-2473.
  • 8Varambally S, Dhanasekaran SM, Zhou M, et al. The polyec, mbgroup protein EZH2 is involved in progression of prostate cancer [J ]. Nature, 2002,419( 6907 ) : 624-629.
  • 9Chang C J, Yang JY, Xia W, et al. EZH2 promotes expansion of breast tumor initiating eells through activation Of RAFi-β-eatenin signaling [ J ]. Cancer Cell, 2011,19 ( 1 ) : 96-100.
  • 10Lu C, Han HD, Mangala LS, et al. Regulation of tumor angiogcnc- sis by EZH2 [J]. Cancer Cell,2010, 18(2): 185-197.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部